Unilever has had a rocky start to the year after mounting three bids for the consumer health arm of GlaxoSmithKline <GSK.L>, - one for as much as 50 billion pounds ($53.14 billion). 
Neutral
Neutral
GlaxoSmithKline
Negative
Negative
Unilever